Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

• Status: Completed
• Trial end date: 2011-03-01

Summary

The aim of the study is to investigate meal-related treatment with either premixed Insulin Aspart 30, Aspart 70 and Aspart with regard to postprandial glucose, triglyceride and free fatty acids excursions after a standard breakfast and lunch.

• Phase: Phase 4

Details

• Lead Sponsor: Medical University of Graz
• Treatments: Biphasic Insulins; Insulin; Insulin Aspart; Insulin aspart, insulin aspart protamine drug combination 30:70; Insulin degludec, insulin aspart drug combination; Insulin, Globin Zinc; Insulin, Isophane; Insulin, Long-Acting